HOME › DRUGS › THALIDOMIDE
ACTIVE SUBSTANCE / INN

THALIDOMIDE

Brand name(s): Thalidomide Lipomed, THALIDOMIDE, THALOMID, Thalidomide BMS (previously Thalidomide Celgene)
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Multiple Myeloma
ANDA213267
ACTIVE SUBSTANCE
Thalidomide
REGULATORS
FDA · EMA
SPONSORS / MAH
NATCO, Lipomed GmbH, Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
THALOMIDNDA020785BRISTOL-MYERSPrescription
THALIDOMIDEANDA213267NATCOPrescription
THALIDOMIDEANDA213267NATCODiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Thalidomide LipomedLipomed GmbHAuthorised19/09/2022Multiple Myeloma
Thalidomide BMS (previously Thalidomide Celgene)Bristol-Myers Squibb Pharma EEIGAuthorised16/04/2008Multiple Myeloma

FULL INTELLIGENCE ON THALIDOMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →